Answers are grounded in this paper and cite their sources.
Background/Objectives: We aimed to explore whether selected non-invasive three-dimensional (3D) body surface indicators differed between prospectively defined enrollment groups and, in linked post-hoc analyses, to identify candidate indicators associated with expert manual judgment. Methods: At screening (visit 1), 88 participants underwent manual examination and pelvic X-ray assessment. Of these, 60 entered the prospective pilot study and underwent 3D body surface analysis at visit 2. The prespecified prospective comparison used the protocol-defined malalignment group (n = 30) and comparison group (n = 30). Final manual diagnosis served as an expert-judgment reference comparator. For post-hoc exploratory ROC analyses, the same 60 participants were reclassified according to final manual diagnosis alone as manual-positive (n = 40) or manual-negative (n = 20). Results: In the prespecified prospective comparison, neither 3D surface-height asymmetry nor marker-angle outcomes differed significantly between the protocol-defined enrollment groups across postures P1–P4. Among all 88 screened participants, X-ray sensitivity and specificity relative to final manual diagnosis were 88.6% and 34.1%, respectively. In the post-hoc exploratory ROC analyses, IC surface-height difference at P3 showed an apparent AUC of 0.684 (p = 0.015), and the highest individual marker-angle AUC was 0.706 at P2 (p = 0.005). An exploratory five-variable model, developed and evaluated in the same dataset, yielded an apparent in-sample AUC of 0.756. Conclusions: The prespecified 3D comparisons did not distinguish the protocol-defined enrollment groups. Post-hoc analyses of the same 60 participants identified candidate 3D indicators associated with expert manual judgment, but these findings were exploratory and do not establish diagnostic accuracy or clinical utility. Prospective validation using prespecified indicators and thresholds, an appropriate independent or composite reference standard, and formal reliability assessment is required before a clinical role for 3D body surface analysis can be determined.
No takes yet. Share an insight, caveat, or question.
Lee et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: